Sentences with phrase «major venture capital companies»

Major venture capital companies are pouring in money, and the industry is well on its way to becoming a major economic force.»

Not exact matches

This metropolitan area (which includes Oakland and Fremont, Calif.) saw the largest proportion of venture capital - backed business exits over the past year compared to other major cities, meaning there are a large number of what Kauffman identifies as «growth companies» in San Francisco and the East Bay.

Tokenized securities startup Harbor has secured $ 28 million in funding from major Silicon Valley venture capital firms, the company announced on Tuesday.

BDC Venture Capital is a major venture capital investor in Canada, active at every stage of the company's development cycle, from seed through expansion, with a focus on innovative technology - based Canadian companies that have high growth potential, offer unique products or services and that are positioned to become dominant players in their mVenture Capital is a major venture capital investor in Canada, active at every stage of the company's development cycle, from seed through expansion, with a focus on innovative technology - based Canadian companies that have high growth potential, offer unique products or services and that are positioned to become dominant players in their mCapital is a major venture capital investor in Canada, active at every stage of the company's development cycle, from seed through expansion, with a focus on innovative technology - based Canadian companies that have high growth potential, offer unique products or services and that are positioned to become dominant players in their mventure capital investor in Canada, active at every stage of the company's development cycle, from seed through expansion, with a focus on innovative technology - based Canadian companies that have high growth potential, offer unique products or services and that are positioned to become dominant players in their mcapital investor in Canada, active at every stage of the company's development cycle, from seed through expansion, with a focus on innovative technology - based Canadian companies that have high growth potential, offer unique products or services and that are positioned to become dominant players in their markets.

At the Venture Association of New Jersey meeting on July 12, 2012, in Whippany, panelists addressed issues surrounding crowdfunding, a major change to capital formation for small tech companies, authorized by the Jumpstart Our Business Startups (JOBS) Act.

A major storyline in venture capital has been the issue of sexual harassment and sexism towards women — particularly company founders but also other investment professionals.

A joint venture of two major gaming companies dropped out of the running for a Capital Region casino.

Table 1: Selection, Design & Construction of HSV - based Oncolytic Viruses Table 2: Selection, Design & Construction of Adenovirus - based Oncolytic Viruses Table 3: Selection, Design & Construction of Vaccinia Virus - based Oncolytic Viruses Table 4: Selection, Design & Construction of Vesicular Stomatitis Virus - based Oncolytic Viruses Table 5: Selection, Design & Construction of Newcastle Disease Virus - based Oncolytic Viruses Table 6: Selection, Design & Construction of Various Virus - based Oncolytic Viruses Table 7: Current Company - Sponsored Clinical Trials of T - Vec Table 8: Clinical Trials of ColoAd1 Table 9: Clinical Trials with JX - 594 Table 10: Clinical Trials with GL - ONC1 Table 11: Clinical Trials of CAVATAK (CVA21) Table 12: Clinical Trials with MV - NIS Table 13: Overview of Oncolytic Viruses by Development Phase & Virus Family Table 14: Profile of Approved and Marketed Oncolytic Viruses Table 15: Pivotal Study Design of Oncolytic Viruses in Late Stage Development Based on Previous Clinical Results Table 16: Approved Indications of Immune Checkpoint Inhibitors Table 17: Active Clinical Studies of Oncolytic Viruses in Combination with Immune Checkpoint Inhibitors (ICI) Table 18: Planned Clinical Studies of Oncolytic Viruses in Combination with Immune Checkpoint Inhibitors (ICI) Table 19: Active or Planned Clinical Studies of Oncolytic Viruses in Combination with Other Anti-Cancer Therapeutics Table 20: Pattern of Transgenes in Oncolytic Viruses in Relation to Development Phase Tables 21a and 21b: Indications and Frquency and Way of Administration of Oncolytic Viruses in Active and / or Positive Completed Clinical Studies Table 22: Small and Medium Pharma & Biotech as Partner for Regional Co-Development of Oncolytic Viruses Table 23: Immuno - Oncology Portfolio of Major Pharma & Biotech with Interest in Oncolytic Viruses Table 24: Interests of Major Pharma & Biotech in Oncolytic Viruses Table 25: First Generation Oncology Virus Companies and their Sources of Technology Table 26: Second Generation Oncology Virus Companies and their Sources of Technology Table 27: Third Generation Oncology Virus Companies and their Sources of Technology Table 28: Fourth Generation Oncology Virus Companies and their Sources of Technology Table 29: Grants, Credits & Donations Table 30: Financing by Venture Capital, Private Equity and Other Private Placements Table 31: Collaboration & Licensing Agreements Table 32: Companies Listed on Stock Exchange & Offerings Table 33: Mergers & Acquisitions

If the extremely promising low cost thin - film technology that is entering high - volume production this year by companies like Nanosolar (100 million in venture capital from the likes of Sergey Brin) pans out, then solar could quickly become a major factor in energy production.

We advise clients at all stages of growth, from early - stage companies across a wide range of fintech industry segments to major multinational corporates, global financial services firms, venture capital firms, asset managers, private equity houses and insurance companies.

This represents a major milestone for the company with the round being led by IVP, one of the premier later - stage venture capital and growth equity firms in the United States.

While small companies opted for leaving New York, major exchanges backed by venture capital such as itBit, Gemini and Bitstamp have applied for the license.

Quan Zhou, managing director of IDG Capital, a major Chinese venture capital company, commented that IDG Capital «looks forward to helping launch the company in the Chinese market where consumer adoption of innovative digital payment products is growing at a tremendous rate.Capital, a major Chinese venture capital company, commented that IDG Capital «looks forward to helping launch the company in the Chinese market where consumer adoption of innovative digital payment products is growing at a tremendous rate.capital company, commented that IDG Capital «looks forward to helping launch the company in the Chinese market where consumer adoption of innovative digital payment products is growing at a tremendous rate.Capital «looks forward to helping launch the company in the Chinese market where consumer adoption of innovative digital payment products is growing at a tremendous rate.»